TrialsgrambetaRCTs are beautiful

2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease

This guideline cites 3 of the 199 landmark trials in our Cardiology register.

The 2020 ESC guideline reverses the field's default posture from restriction to prescription: exercise is recommended in almost every cardiovascular condition, and the burden of proof now lies with those who would forbid it. It also abandons blanket disqualification in hypertrophic cardiomyopathy in favour of shared, risk-stratified decisions. The register's exercise-training trials are grouped below.

Exercise training in heart failure2

  • 2017SMARTEX-HF⁠Cardiology · HF · Exercise intensityIn 261 patients with heart failure and reduced ejection fraction, 12 weeks of supervised high-intensity interval training produced no greater reverse remodelling or gain in left ventricular end-diastolic diameter and peak oxygen uptake than moderate continuous training.Read →
  • 2009HF-ACTION⁠Cardiology · HF · Exercise trainingIn 2,331 patients with heart failure and reduced ejection fraction, a supervised aerobic exercise-training programme did not significantly reduce all-cause mortality or hospitalisation compared with usual care.HR 0.9395% CI 0.84-1.02Read →

Exercise in hypertrophic cardiomyopathy1

  • 2017RESET-HCM⁠Cardiology · HF · Exercise in cardiomyopathyIn 136 adults with hypertrophic cardiomyopathy, 16 weeks of moderate-intensity aerobic exercise training produced a small increase in peak oxygen consumption, with no ventricular arrhythmias, compared with usual activity.Read →

Published since the guideline1

  • 2025Ex-DHF⁠Cardiology · HF · Exercise trainingIn 322 patients with heart failure and preserved ejection fraction, 12 months of supervised endurance and resistance training did not significantly improve a hierarchical composite of death, hospitalisation, peak oxygen uptake, diastolic function and symptoms compared with usual care, although peak oxygen uptake and NYHA class improved.20.5% vs 8.1%Read →

Cited landmark trials not yet in the register4

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

  • 2011Ex-DHF-P

    The pilot trial of exercise training in HFpEF that preceded Ex-DHF.

  • 2021OptimEx-Clin

    High-intensity interval versus moderate continuous training in HFpEF — neither reached the clinically important threshold.

  • 2004EXTRAMATCH

    The meta-analysis that first suggested a survival benefit of exercise training in heart failure.

  • 2023LIVE-HCM

    Prospective cohort — vigorous exercise in hypertrophic cardiomyopathy was not associated with excess events.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.